Iowa Roundup Cancer Lawsuit: What Legal Rights Remain After the Supreme Court’s Preemption Ruling
If you are an Iowa farmer, an agricultural worker, a landscaper, or someone who worked at the plant in Muscatine where seventy percent of the Roundup sold in North America is manufactured — and you have been diagnosed with cancer — you are reading this at a specific and frightening moment. The Supreme Court of the United States has just ruled that Bayer cannot be sued for failing to warn people that the weedkiller Roundup could cause cancer. You may be hearing that ruling described as the end of the road. We need you to hear the whole truth before you decide that, because the ruling closes one door — the failure-to-warn door — and the company’s lawyers and the insurance adjusters are counting on you not knowing that other doors remain. This page is written by the trial team at Attorney911 to tell you, in plain language, exactly what the ruling does and does not do, what legal theories may still be available to you under Iowa law, what evidence you need to preserve right now before it legally disappears, and what your case may actually be worth when the right theory is matched to the right proof. We are a trial firm that takes toxic tort and product liability cases in Iowa, working with local counsel where required. The consultation is free. We do not get paid unless we win your case. And the day you call is the day the clock on your evidence starts working for you instead of against you.
What the Supreme Court Ruling Actually Does — and What It Does Not Do
The Supreme Court held that Bayer, which acquired Monsanto in 2018 and with it the Roundup product line, cannot be sued under state law for failing to warn consumers that Roundup could cause cancer. The legal basis is federal preemption under the Federal Insecticide, Fungicide, and Rodenticide Act — FIFRA — the federal statute that governs pesticide registration, labeling, and distribution nationwide. Under FIFRA, the Environmental Protection Agency reviews and approves pesticide labels. The Court’s ruling holds that this federal approval process preempts state-law failure-to-warn claims that would require warnings different from or additional to those the EPA approved.
In plain English: the company put a label on the product, the federal government approved that label, and the Supreme Court has now said that you cannot sue the company in state court arguing that the label should have carried a cancer warning the EPA did not require.
That is a serious setback. Failure to warn was the legal theory that drove the largest Roundup verdicts in U.S. history — verdicts that were among the biggest product liability awards ever returned by American juries. That theory is now substantially foreclosed.
But — and this is the part the company will not put in its press release — the ruling addresses failure to warn specifically. It does not necessarily foreclose every product liability theory. Other legal theories may remain viable, depending on your exposure history and the manufacturer’s conduct. The fight has shifted, not ended.
“Iowa farmers rely on safe and effective pesticides. The path to get to safe and effective herbicides is not to give blanket protections to pesticide manufacturers that have a clear link to cancer.” — Aaron Lehman, Iowa Farmers Union president, public statement on the ruling
The Iowa Farmers Union president called the decision a “huge step backward for Iowa farmers.” He pointed out what every Iowan in agriculture already knows: “We have a real cancer problem here in Iowa, and farming is already dangerous enough. So putting more barriers between farmers and their ability to protect their health and defend their health is a bad idea.” Iowa’s governor candidates criticized the ruling. Congress and the Iowa Legislature had both rejected legislative proposals that would have limited pesticide-related lawsuits — meaning the elected branches chose not to close the courthouse door, and the judicial branch did it through preemption doctrine instead.
Bayer’s CEO said the decision is good for American farmers. The farmers who got cancer after years of spraying Roundup have a different view of what is good for them.
The Legal Theories That May Survive the Preemption Ruling
This is where the post-ruling Roundup case lives or dies, and it requires the precision of an appellate attorney who understands exactly where preemption stops and where other theories begin. The Supreme Court’s ruling forecloses failure-to-warn claims — claims that the label was inadequate because it did not warn of cancer risk. But three other theories may survive because they are not premised on the content of the EPA-approved label.
Design defect. A design defect claim argues that Roundup is inherently unreasonably dangerous in its formulation — that the product itself, as designed and manufactured, is dangerous beyond what a reasonable consumer would expect, or that the risks of the design outweigh its utility and a reasonable alternative design existed. This theory is independent of labeling. It attacks the product, not the warning. The preemption ruling, which addresses label content, does not squarely address this theory. If a plaintiff can demonstrate that the glyphosate formulation is unreasonably dangerous in its design — that a safer alternative existed, that the foreseeable risks of the formulation outweigh its benefits — this claim may survive where failure to warn does not.
Fraud, intentional misrepresentation, or active concealment. This is potentially the most powerful surviving theory. If the evidence shows that Bayer or Monsanto actively suppressed or misrepresented cancer-risk data — not merely stayed silent on the label, but took affirmative steps to mislead regulators, the scientific community, or the public about glyphosate’s carcinogenic potential — that is a different animal from a passive failure to warn. Active concealment may survive preemption where passive label silence does not. The distinction matters enormously: a fraud theory opens the door to punitive damages under Iowa law if the plaintiff can demonstrate willful, wanton, or reckless conduct. And the internal corporate documents from prior Roundup discovery — scientific studies, risk assessments, internal communications about glyphosate’s carcinogenicity — are the raw material from which a fraud or concealment case is built.
Negligent testing and product safety. This theory may survive if it is grounded in allegations that the manufacturer failed to conduct adequate safety testing — not that the label was wrong, but that the company never properly tested the product for cancer risk in the first place, or ignored testing results that showed danger. Again, this is a claim about the manufacturer’s conduct in the laboratory and the boardroom, not about the words on the approved label.
Each of these theories requires a distinct evidentiary foundation, and each faces its own challenges. But the critical point for you is this: the Supreme Court ruling does not say “you cannot sue Bayer for Roundup.” It says you cannot sue for failure to warn. Other theories, grounded in different conduct and different proof, may remain.
Iowa’s Unique Connection: The Muscatine Plant and the State’s Cancer Burden
This ruling hits Iowa harder than almost any other state, and the reason is sitting on the Mississippi River in Muscatine County. Seventy percent of the Roundup sold in North America is manufactured at a plant in Muscatine, Iowa. That single facility is the production hub for a product that has been sprayed across millions of acres of American farmland — and across the corn and soybean corridors of Iowa in particular, where herbicide application is a seasonal rhythm of the agricultural economy and a large workforce is exposed to repeated, sustained glyphosate contact year after year.
For someone who worked at that plant, the exposure story is different from a farmer who sprayed fields. Plant workers may have had occupational exposure through manufacturing processes — direct handling of concentrated glyphosate, inhalation of process emissions, dermal contact during formulation and packaging. The plant’s operational history, emission controls, worker safety protocols, air-monitoring data, and OSHA injury and illness logs would be central to any occupational exposure claim arising from the facility. OSHA Form 300 records — the employer’s log of work-related injuries and illnesses — are retained for five years. Plant monitoring data is subject to state and corporate retention policies that vary. These records are perishable, and they are specific to the Muscatine facility.
For the broader Iowa agricultural workforce — farmers, farmhands, custom applicators, crop dusters, groundskeepers, landscapers — the exposure story runs through years of seasonal spraying. Purchase receipts, farm application logs, spray records, equipment calibration logs, and pesticide application records establish the duration, frequency, and concentration of Roundup exposure specific to the individual. These are the records that prove your dose, and in a toxic tort case, dose is everything.
Iowa experiences some of the highest cancer incidence rates in the nation. Agricultural-health researchers have linked this statistic to sustained pesticide exposure among farming populations. The state’s governor candidates have publicly opposed shielding pesticide companies from cancer lawsuits. The political and public-health context matters because it shapes the environment in which your case would be filed — in an Iowa county courthouse, before a jury of your neighbors, people who understand what it means to live and work in farm country.
Who May Still Have a Viable Claim
The universe of potential plaintiffs in a post-ruling Roundup case is not limited to one type of worker. It includes several distinct categories, each with its own exposure pathway and its own legal considerations.
Farmers and agricultural workers who applied Roundup. This is the core group — people who mixed, loaded, sprayed, or otherwise handled Roundup over a period of years and were later diagnosed with cancer, most commonly Non-Hodgkin lymphoma. Independent operators and owner-occupier farmers have direct access to tort remedies against the product manufacturer. Agricultural workers who are employees may face workers’ compensation exclusivity barriers that channel their claim through the comp system rather than the civil courts, but the manufacturer — Bayer/Monsanto — is a third-party defendant who is not shielded by the employer’s comp coverage. That third-party claim against the manufacturer is the path to full tort damages.
Muscatine plant employees. Workers at the manufacturing facility may have had occupational exposure through the production process itself. Their exposure pathway is different from field application — potentially more concentrated, more sustained, and more directly documented through workplace monitoring. The plant’s safety records, emission data, and worker monitoring files are the evidence spine for these claims.
Landscapers, groundskeepers, and commercial applicators. People who used Roundup professionally in non-agricultural settings — parks, golf courses, commercial properties, residential landscaping — were also exposed repeatedly over years. Their purchase records, employer application logs, and work histories establish the exposure timeline.
Family members of deceased exposed workers. If your loved one used Roundup for years, developed Non-Hodgkin lymphoma, and died from the disease or its complications, a wrongful death claim may be available. Iowa’s wrongful death statute allows specific beneficiaries to recover — and the discovery rule for toxic exposure cases may mean the statute of limitations clock did not start running until the connection between the exposure and the cancer was known or should have been known. Wrongful death claims carry their own damage elements under Iowa law, and the family’s right to pursue accountability does not end with the Supreme Court’s failure-to-warn ruling.
Iowa’s Statute of Limitations and the Discovery Rule
Iowa’s statute of limitations for personal injury and wrongful death is generally two years. That is a short clock, and in most ordinary injury cases it starts running on the date of the injury. But toxic exposure cases are not ordinary injury cases, and Iowa law recognizes the discovery rule — a doctrine that may toll, or delay, the start of the limitations period until the plaintiff knew or reasonably should have discovered the injury and its causal connection to the exposure.
In a Roundup cancer case, the injury — cancer — may have been diagnosed years or even decades after the exposure began. Non-Hodgkin lymphoma has a latency period; it does not appear overnight. The question of when the clock started running may turn on when you were diagnosed, when you first learned that your cancer might be connected to Roundup exposure, and when a reasonable person in your position would have made that connection.
This is not a question you should try to answer alone, and it is not a question you should guess at. The difference of a few months can be the difference between a viable case and a case that is time-barred forever. If you were diagnosed with Non-Hodgkin lymphoma and you have a history of Roundup use — whether on a farm, at the Muscatine plant, or in a commercial application job — the safest thing you can do is have the deadline evaluated by a lawyer now, while the clock and the evidence are both still alive.
Iowa follows a modified comparative negligence standard with a 51 percent bar. That means your own share of fault reduces your recovery proportionally, and if you are assigned 51 percent or more of the fault, you cannot recover at all. In a Roundup case, the defense will try to pin fault percentages on the exposed worker — arguing that you failed to wear protective equipment, that you mixed the product too concentrated, that you sprayed on windy days. Every percentage point they assign to you is money off the recovery. Iowa does not impose broad caps on non-economic damages in most personal injury actions, though specific statutory caps may apply in medical malpractice contexts. For a toxic tort product liability case against a manufacturer, the non-economic damage stream — pain, suffering, emotional distress, loss of quality of life — is generally not capped, which means the full human cost of the cancer is compensable.
The Defendant: Bayer AG and Monsanto’s Corporate Structure
Bayer AG, the German pharmaceutical and chemical conglomerate, acquired Monsanto Company in 2018 for $63 billion. Monsanto was the original developer and manufacturer of Roundup, and the product’s active ingredient — glyphosate — was first brought to market by Monsanto in the 1970s. After the acquisition, Monsanto became a wholly-owned subsidiary of Bayer, and the Roundup litigation followed it into the corporate family.
In the consolidated federal litigation — the multidistrict litigation proceeding in the Northern District of California before Judge Vince Chhabria — the caption defendant remains “Monsanto Company,” even though the deep pocket behind it is Bayer. As of the most recent JPML pending docket report, approximately 3,909 actions were pending in the Roundup MDL, with total actions exceeding 5,000. Those numbers shift as cases are resolved, transferred, or filed, and the Supreme Court’s ruling will reshape the trajectory of the entire docket.
The corporate-structure reality matters for your case. The entity that designed, manufactured, marketed, and distributed Roundup is Monsanto. The entity that assumed that liability when it acquired Monsanto is Bayer. Internal corporate documents — scientific studies, risk assessments, communications about glyphosate carcinogenicity — may sit in the files of either entity, and in the files of predecessor companies and contractors. A thorough defendant-identification effort names the right entities and reaches for the right insurance and corporate records.
Bayer’s approach to the Roundup litigation has been aggressive and strategic. The company has argued that glyphosate is safe, that the EPA has consistently found it not likely to be carcinogenic to humans, and that federal labeling approval preempts state-law claims. The Supreme Court’s ruling validates the preemption argument for failure-to-warn claims. But the company’s own internal documents — much of which were produced in prior Roundup discovery but require active litigation to access and catalog — are the evidence that may support the surviving fraud, concealment, and negligent-testing theories.
Evidence Preservation: What Records Exist and How Fast They Disappear
This is the section that may matter more than any other, because the evidence in a toxic exposure cancer case is perishable in ways most people never imagine. Every record below exists somewhere, held by someone, and every one of them is on a clock. The preservation letter — the formal demand that a company, a hospital, an employer, or a government agency lock down specific records and not destroy them — is the single most time-sensitive step in a Roundup case, and it goes out the day you call.
Personal exposure documentation. Purchase receipts for Roundup, farm application logs, spray records, equipment calibration logs, pesticide application permits, and employer work records showing when and how often you handled the product. These establish the duration, frequency, and concentration of your Roundup exposure. Farm records are often discarded or destroyed within years — agricultural business records have limited retention cycles, and a farmer who retired or scaled back may not have kept spray logs from ten or twenty years ago. If you still have these records, preserve them immediately. If your employer has them, the preservation letter goes to the employer.
Medical records. Pathology reports, cancer diagnosis documentation, treatment history, oncology records, chemotherapy and radiation records, bone marrow transplant records, and ongoing surveillance imaging. These establish specific causation — documenting the cancer type, the diagnosis date, and the treatment course necessary to link exposure to injury. Medical records are generally retained long-term by hospitals and clinics, but obtaining complete historical records becomes harder with time, especially if you have changed providers or moved.
Bayer and Monsanto internal corporate documents. Scientific studies, risk assessments, internal communications about glyphosate carcinogenicity, regulatory correspondence, and marketing materials. These support the fraud and concealment theory by showing what the manufacturer knew about cancer risks and when — and whether it actively suppressed or misrepresented that information rather than merely failing to put it on the label. Much of this material was produced in prior Roundup discovery, but cataloging and accessing it requires active litigation. Subject to corporate retention policies, these documents may not be publicly available without a subpoena or discovery request.
EPA registration and correspondence files. Label approval history, scientific reviews, communications between the registrant and the EPA, and any data submitted during the registration process. These define the scope of preemption by showing what the EPA actually approved — and whether any fraud or misrepresentation infected the registration process itself. Federal records are retained under National Archives schedules, but FOIA processing delays make early requests critical. If the manufacturer misled the EPA during the registration process, the preemption shield may be vulnerable — a company that obtained federal label approval through fraud may not be able to use that approval as a sword to block state-law claims.
Muscatine plant operational records. Emission data, worker monitoring results, safety audits, OSHA Form 300 logs, air-sampling records, and process-safety documentation. These are relevant to any occupational exposure claim arising from the manufacturing facility rather than field application. OSHA Form 300 records are retained for five years. Plant monitoring data is subject to state and corporate retention policies that may be shorter or longer.
The fastest-dying evidence drives the urgency. The preservation letter that freezes these records has to go out before the clock runs — not after the insurance company calls, not after you finish treatment, not after you “see how things go.” The day you call a lawyer is the day that letter goes into the mail.
The Medicine: Non-Hodgkin Lymphoma and Glyphosate Exposure
Non-Hodgkin lymphoma is the cancer most frequently associated with Roundup exposure in the litigation. It is a cancer of the lymphatic system — the body’s network of lymph nodes, spleen, thymus, and bone marrow that produces and transports white blood cells. NHL encompasses a diverse group of blood cancers that arise from lymphocytes, the white blood cells that fight infection. There are many subtypes, and the specific subtype you were diagnosed with matters for both treatment and for the causation analysis in your case.
The mechanism by which glyphosate may cause NHL is studied but not fully settled. The International Agency for Research on Cancer — IARC, the World Health Organization’s cancer research arm — classified glyphosate as “probably carcinogenic to humans” (Group 2A) in 2015, citing limited evidence of cancer in humans and sufficient evidence in cancer in experimental animals. The EPA has taken a different position, finding that glyphosate is “not likely to be carcinogenic to humans.” This regulatory disagreement is one of the central scientific battlegrounds of the Roundup litigation, and it is a fight that the Supreme Court’s preemption ruling does not resolve — the ruling addresses the legal question of label preemption, not the scientific question of whether glyphosate causes cancer.
What this means for your case is that general causation — whether glyphosate can cause Non-Hodgkin lymphoma in humans — remains a live and contested scientific question that must be proven through expert testimony in toxicology, epidemiology, and oncology. Specific causation — whether your Roundup exposure caused your specific cancer — requires dose reconstruction from your exposure history, analysis of latency periods, and differential diagnosis ruling out alternative causes. Both are battles, and both require the right experts and the right evidence.
The defense will exploit the latency and the multiplicity of causes. Non-Hodgkin lymphoma has many known and suspected risk factors — age, immune system suppression, certain infections, family history, other chemical exposures. The defense will argue that your cancer was idiopathic, or caused by something else, or that you cannot prove your specific exposure was sufficient to cause your specific cancer. The counter lives in the exposure records, the dose reconstruction, and the epidemiological literature — and in the internal corporate documents that may show the manufacturer knew more than it disclosed about the cancer risk.
For the family watching it happen, the medicine is not abstract. Chemotherapy, radiation, immunotherapy, bone marrow transplants, remission and relapse, surveillance scans every three months, the bone-marrow biopsy, the port placement, the hair loss, the nausea, the infections from a suppressed immune system, the fear that lives in every swollen lymph node — this is what Non-Hodgkin lymphoma looks like from the kitchen table. The medical record documents all of it, and the life-care plan prices it across a lifetime.
What Compensation Is Available
The damages in a glyphosate exposure cancer case fall into several categories, each of which must be built and proven separately. The Supreme Court’s ruling weakens the failure-to-warn theory that historically supported large verdicts, but it does not eliminate the compensable losses — it changes the legal theory through which you seek to recover them.
Economic damages include past and future medical expenses for cancer treatment. This is the hospital bills, the oncologist visits, the chemotherapy infusions, the radiation sessions, the surgical interventions, the bone marrow transplant costs, the ongoing surveillance imaging, the prescription medications, and the future medical care that a life-care planner projects across your expected lifespan. For a farmer whose physical labor is their livelihood, lost wages and diminished earning capacity may be devastating — cancer takes you out of the field, sometimes for a season, sometimes forever. The life-care plan prices every cost category in today’s dollars, and the forensic economist reduces it to present value. The adjuster’s first offer will be a fraction of this number, and knowing how the real number is built is how you refuse to accept the fraction.
Non-economic damages include physical pain, emotional distress, loss of quality of life, and the psychological toll of a cancer diagnosis and its treatment. Iowa does not impose broad caps on non-economic damages in most personal injury actions, which means the full human cost of the cancer is compensable. The fear of recurrence, the loss of the life you planned, the strain on your marriage and your family, the days you could not get out of bed — these are real losses with real dollar values, and a jury in your county is allowed to compensate them.
Punitive damages may be available under Iowa law if the plaintiff demonstrates willful, wanton, or reckless conduct. The preemption ruling weakens the failure-to-warn theory that historically supported punitive claims, but a fraud or active-concealment theory — if supported by internal corporate documents showing the manufacturer suppressed or misrepresented cancer-risk data — may carry its own punitive exposure. Punitive damages are the category that punishes the company for its conduct, and they are the category that changes how the company behaves going forward. Whether punitive damages are available in a post-ruling case depends entirely on whether a surviving non-preempted theory — fraud, concealment, negligent testing — can be proven with the requisite state of mind.
Survival and wrongful death actions carry separate damage elements under Iowa law. If your loved one died from Roundup-associated cancer, the wrongful death claim belongs to the statutory beneficiaries and compensates the family’s losses — lost financial support, lost companionship, lost guidance. The survival action belongs to the estate and carries the claim the deceased person would have had — the pain and suffering experienced between injury and death, the medical expenses, the funeral costs. Confirm the current Iowa survival-versus-wrongful-death damage split with counsel, as the specific elements and their allocation are matters of state statute.
Case value in a post-ruling Roundup case depends entirely on four variables: the plaintiff’s exposure history (duration, frequency, concentration), the cancer type and stage at diagnosis, the plaintiff’s age and earning capacity, and whether a surviving non-preempted theory — design defect, fraud, or negligent testing — can be proven with strong specific causation evidence. Prior Roundup verdicts before the Supreme Court ruling included some of the largest product liability awards in U.S. history. The failure-to-warn preemption ruling substantially narrows recoverable theories and likely reduces individual case values. But where fraud or design defect can be established, and where specific causation is strong, the exposure remains in the multi-million-dollar range for individual cancer cases. Honest evaluation requires a case-specific assessment by counsel who understands both the medicine and the post-ruling legal landscape.
Past results depend on the facts of each case and do not guarantee future outcomes.
How the Defense Will Respond: The Insurance and Corporate Playbook
Bayer and Monsanto are among the most sophisticated defendants in the world. They have fought the Roundup litigation for years, they have a playbook, and the Supreme Court ruling just handed them the strongest card in it. Here is what to expect, and here is the counter to each move.
Play one: “Preemption bars everything.” The company will argue that the Supreme Court’s ruling is broader than it is — that preemption under FIFRA forecloses not just failure-to-warn claims but all state-law claims related to Roundup. The counter: the ruling addresses failure to warn specifically. Design defect, fraud, and negligent testing are distinct theories that are not premised on label adequacy. The company will push the broadest possible reading of the ruling; the plaintiff’s job is to hold the line at the actual holding and force the company to litigate the surviving theories on their merits.
Play two: “The EPA says glyphosate is safe.” The company will lean heavily on the EPA’s position that glyphosate is not likely to be carcinogenic to humans. The counter: the IARC — the World Health Organization’s cancer research arm — reached a different conclusion, classifying glyphosate as probably carcinogenic. The regulatory disagreement is itself a fact for the jury, and the EPA’s position does not resolve the scientific question of whether glyphosate causes Non-Hodgkin lymphoma. Moreover, if the manufacturer misled the EPA during the registration process, the EPA’s conclusion may rest on incomplete or distorted data — which is exactly what the fraud theory targets.
Play three: “Your cancer came from something else.” The defense will argue that Non-Hodgkin lymphoma has many causes, that your cancer was idiopathic or caused by age, immune suppression, or other chemical exposures, and that you cannot prove your specific Roundup exposure caused your specific cancer. The counter: dose reconstruction from your exposure records, the epidemiological literature on glyphosate and NHL, differential diagnosis ruling out alternative causes, and the IARC classification. Specific causation is a battle, but it is a battle that can be won with the right experts and the right exposure documentation.
Play four: the quick settlement offer. After the ruling, the company may move to resolve remaining claims quickly — at values that reflect the reduced leverage from the loss of the failure-to-warn theory. A check may arrive with a release attached, designed to close the file before you understand what your case is worth under a surviving theory. The counter: never accept a settlement offer before a lawyer has evaluated your case under the post-ruling legal landscape, including the potential value of fraud-based punitive claims. The first offer is always a fraction of the real value, and the release is permanent.
Play five: “You waited too long.” The defense will argue that the statute of limitations has expired. The counter: the discovery rule may toll the limitations period in toxic exposure cases until you knew or should have known of the injury and its causal connection to the exposure. When the clock started is a legal question that depends on the specific facts of your diagnosis and your awareness of the Roundup-cancer connection — and it is a question that requires legal analysis, not a guess.
How a Post-Ruling Roundup Case Is Built
Here is how a case like this is actually built, week by week, from the day you call to the day a number is on the table. This is the proof story, and it is told by someone who has run it.
Week one. The preservation demand goes out — to Bayer, to Monsanto, to any employer whose records document your exposure, to the Muscatine plant if you worked there, to every hospital and clinic that treated your cancer. The letter names every record category by name: exposure monitoring data, application logs, purchase receipts, internal corporate documents about glyphosate carcinogenicity, EPA registration correspondence, OSHA logs, medical records, pathology reports. The letter puts every recipient on notice that evidence destruction after receipt is spoliation, and that a court may impose sanctions — including an adverse-inference instruction telling the jury to assume the lost records were as bad as the plaintiff says — if records are destroyed.
The exposure reconstruction. Your purchase receipts, your spray logs, your employer’s application records, your work history — these are assembled into a dose timeline. How many years did you use Roundup? How many days per season? What concentration? What application method — boom sprayer, backpack sprayer, hand-held? Did you mix the concentrate? Did you wear gloves, a mask, protective clothing? The industrial hygiene expert takes these facts and reconstructs your cumulative exposure dose — the number that the toxicologist and the oncologist will use to evaluate whether your exposure was sufficient to cause your cancer.
The medical record assembly. Every pathology report, every oncology note, every chemotherapy record, every surveillance scan, every hospital admission — these are assembled into the medical timeline. The cancer type and subtype, the stage at diagnosis, the treatment course, the response to treatment, the remission or relapse status, the prognosis. The treating oncologist’s records are the backbone, and a plaintiff’s oncology expert ties the medical picture to the exposure picture through specific causation analysis.
The corporate document discovery. In litigation, the plaintiff serves discovery demands on Bayer and Monsanto for internal documents — scientific studies, risk assessments, internal communications about glyphosate and cancer, regulatory submissions, marketing materials, and the documents that prior Roundup discovery surfaced but that require active cataloging and access. These are the documents that may distinguish a fraud or concealment theory from a mere failure to warn — and they are the documents that may support punitive damages if they show the company knew more than it disclosed.
The expert team. A toxicologist to address general causation — whether glyphosate causes Non-Hodgkin lymphoma. An epidemiologist to address the statistical association between glyphosate exposure and NHL in human populations. An industrial hygienist to reconstruct your exposure dose. An oncologist to address specific causation — whether your exposure caused your cancer. A life-care planner to build the future-cost stream. A forensic economist to reduce it to present value. Each expert’s opinion must be grounded in the record and the literature, and each must survive the defense’s challenge to admissibility.
The depositions. The corporate witnesses — the scientists, the regulatory affairs personnel, the executives who decided what to disclose and what to suppress — are deposed under oath. Their testimony, measured against the internal documents, is where the fraud or concealment case is built or broken. The defense experts are deposed on their methodology, their reliance on the EPA’s position, and their alternative-causation opinions.
The number. At the end of all of this — the exposure reconstruction, the medical assembly, the corporate document discovery, the expert opinions, the depositions — the number is built. The life-care plan prices the future medical care. The economist projects the lost earning capacity. The non-economic damages are valued from the medical record and the human toll it documents. And if the fraud theory is supported, the punitive exposure is evaluated. That number — the full, honest, built-from-the-record number — is the floor of any settlement discussion, and it is the number we put before a jury if the company will not meet it.
Your First Steps: Evidence, Records, and Timing
If you are reading this page and you have been diagnosed with cancer after years of Roundup exposure, here is what you should do — and what you should not do — in the days and weeks ahead.
Do gather your exposure records now. Purchase receipts, farm application logs, spray records, equipment calibration logs, pesticide application permits — anything that documents when, how often, and how much Roundup you used. If you worked at the Muscatine plant, gather any employment records, safety training materials, and work history documentation you have. If you were a commercial applicator or landscaper, gather employer work records and application logs. These records are the foundation of your exposure dose, and they are the records most likely to be discarded or lost with time.
Do gather your medical records. Pathology reports, diagnosis documentation, treatment history, oncology records — these establish the cancer that is the injury in your case. If you have changed providers or moved, track down the earlier records now, while the clinics and hospitals that hold them are still in operation and the records are still within their retention periods.
Do not sign anything from Bayer, Monsanto, or any insurance company. A release is permanent. A settlement check that arrives with a release attached — before you have had your case evaluated, before you understand what a surviving theory may be worth — is designed to close your file at the lowest possible number. Do not sign it. Do not cash it. Do not return the paperwork. Call a lawyer first.
Do not give a recorded statement. If an insurance adjuster or a company representative calls and asks you to “just tell us what happened” on a recording, decline. Recorded statements are engineered to be quoted against you — to lock you into a version of events before you have had a chance to review your own records, to get you to say “I feel okay” when the full extent of your cancer is not yet known, to minimize your exposure history from memory when the documentation tells a different story. The adjuster is not your friend. The recording is not for your benefit.
Do not post about your case on social media. The defense will mine your social media for anything that can be used to minimize your injury — a photo of you at a family picnic captioned “feeling great,” a post about working in the yard, a comment about feeling better after treatment. These are taken out of context and presented to a jury as evidence that your cancer is not as serious as you claim. Set your accounts to private and stop posting about your health, your work, or your legal situation.
Do call a lawyer now. The consultation is free. The preservation letter goes out the day you call. The evidence starts being protected. The statute of limitations is evaluated. And the surviving legal theories — design defect, fraud, negligent testing — are assessed against the specific facts of your exposure and your diagnosis. The day you call is the day the machinery of your case starts moving.
Frequently Asked Questions
Can I still sue Bayer for Roundup cancer after the Supreme Court ruling?
The Supreme Court ruling forecloses failure-to-warn claims — claims that the product label should have carried a cancer warning the EPA did not require. It does not necessarily foreclose all product liability theories. Design defect claims, fraud or active concealment claims, and negligent testing claims may survive because they are not premised on the content of the EPA-approved label. Whether you have a viable claim depends on your exposure history, your cancer diagnosis, and whether a surviving legal theory can be proven with your specific evidence. An attorney can evaluate your case under the post-ruling legal landscape.
How long do I have to file a Roundup cancer lawsuit in Iowa?
Iowa’s statute of limitations for personal injury and wrongful death is generally two years. However, in toxic exposure cases, the discovery rule may toll — or delay — the start of the limitations period until you knew or reasonably should have discovered the injury and its causal connection to the exposure. In a Roundup cancer case, the clock may not start on the date of your exposure but on the date you were diagnosed with cancer and learned or should have learned of the connection to Roundup. This is a case-specific legal question that requires evaluation by counsel. Do not assume you have missed the deadline without having it evaluated.
What kind of cancer is linked to Roundup exposure?
Non-Hodgkin lymphoma is the cancer most frequently associated with Roundup exposure in the litigation. The International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans in 2015, citing limited evidence of cancer in humans and sufficient evidence in experimental animals. The EPA has taken a different position. Whether your specific cancer can be linked to your specific Roundup exposure is a question of specific causation that requires expert analysis of your exposure dose, your medical history, and the epidemiological literature.
I worked at the Muscatine Roundup plant. Is my case different from a farmer’s?
It may be. Plant workers may have had occupational exposure through the manufacturing process — potentially more concentrated and more directly documented through workplace monitoring than field application. The plant’s operational records — emission data, worker monitoring, safety audits, OSHA logs — are the evidence spine for an occupational exposure claim. OSHA Form 300 records are retained for five years. The legal theories available to you may include the same product liability theories — design defect, fraud, negligent testing — and your exposure documentation may be stronger because it comes from employer monitoring records rather than personal spray logs.
What if my family member died from Roundup-related cancer?
If your loved one used Roundup for years, developed Non-Hodgkin lymphoma, and died from the disease or its complications, a wrongful death claim may be available to the statutory beneficiaries under Iowa law. A separate survival action may be available to the estate for the deceased person’s pain and suffering between injury and death, plus medical expenses and funeral costs. The discovery rule for toxic exposure cases may apply to the limitations period. The Supreme Court’s failure-to-warn ruling does not eliminate wrongful death claims — it narrows the legal theories through which they may be pursued. An attorney can evaluate the specific beneficiaries, the damage elements, and the deadline.
What is my Roundup cancer case worth?
Case value in a post-ruling Roundup case depends on four variables: your exposure history (duration, frequency, concentration), your cancer type and stage, your age and earning capacity, and whether a surviving non-preempted theory — design defect, fraud, or negligent testing — can be proven with strong specific causation evidence. Economic damages include past and future medical expenses, lost wages, and diminished earning capacity. Non-economic damages include pain, suffering, emotional distress, and loss of quality of life — and Iowa does not impose broad caps on non-economic damages in most personal injury actions. Punitive damages may be available under Iowa law if willful, wanton, or reckless conduct is demonstrated — and a fraud or concealment theory may carry its own punitive exposure. Prior Roundup verdicts before the Supreme Court ruling included some of the largest product liability awards in U.S. history, but the ruling substantially narrows recoverable theories and likely reduces individual case values. Honest evaluation requires a case-specific assessment.
Will I have to go to trial?
Most product liability cases settle before trial, but the possibility of trial is what drives the settlement value. The company’s willingness to offer a fair settlement depends on its assessment of what a jury in your county would do if the case went to trial — and that assessment depends on the strength of your evidence, the surviving legal theory, and the quality of the expert testimony. A firm that is prepared to try the case is a firm that can settle the case. A firm that is not prepared to try the case will accept the first offer.
How much does it cost to hire a lawyer for a Roundup cancer case?
We work on contingency. That means we do not charge an hourly fee and we do not charge a consultation fee. The consultation is free. We advance the costs of the case — the expert fees, the filing fees, the discovery costs — and we are paid only if we recover money for you. Our fee is 33.33 percent of the recovery before trial and 40 percent if the case goes to trial. We do not get paid unless we win your case. If there is no recovery, you owe us nothing for attorney’s fees or the costs we advanced.
Why Attorney911
We are Attorney911 — The Manginello Law Firm, PLLC. We are Legal Emergency Lawyers. We take product liability and toxic tort cases in Iowa, working with local counsel where required, and we have been doing this work since 2001.
Ralph Manginello is our Managing Partner — 27+ years of trial practice, a journalist before he was a lawyer, a competitor who hates losing. He is admitted in Texas state court and federal court, and he has spent his career in the courtroom on the kinds of cases where the defendant is a corporation and the injured person is a human being. Lupe Peña is our associate attorney — a former insurance-defense attorney who spent years inside a national defense firm, in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. He knows how the other side prices a claim, how it sets reserves in the first 48 hours, how it picks its IME doctors, and how it engineers the recorded-statement call — because he used to do it. Now he uses that knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter. We serve your family fully in both languages. Hablamos Español.
The Roundup litigation just changed. The Supreme Court closed the failure-to-warn door, and the company is counting on that being the end of the conversation. It is not. Other theories may survive. Other evidence may exist. And the internal corporate documents that prior discovery surfaced — the scientific studies, the risk assessments, the communications about glyphosate and cancer — are the raw material from which a fraud or concealment case is built. We know how to build that case. We know how to find the records before they disappear. We know how to price a cancer claim from the inside, because Lupe sat in the rooms where the other side priced them.
The call is free. The consultation is free. We do not get paid unless we win your case. The preservation letter goes out the day you call — because the evidence that proves your exposure and your cancer is on a clock, and the company is counting on that clock running out before you act.
Call 1-888-ATTY-911 — that is 1-888-288-9911 — or contact us through our website. Twenty-four hours a day, seven days a week, a live person answers — not an answering service. If you are an Iowa farmer, an agricultural worker, a Muscatine plant employee, or the family of someone who was diagnosed with cancer after years of Roundup exposure, we will evaluate your case under the post-ruling legal landscape, tell you honestly whether a surviving theory is viable, and if we are not the right fit for your case, we will tell you that too.
This page is legal information, not legal advice. Past results depend on the facts of each case and do not guarantee future outcomes. Contacting the firm is free and confidential. The Supreme Court’s ruling changed the Roundup litigation — it did not end it. Find out what remains.